|
Barry Callebaut signs pact with Naturex on use of cocoa flavanols claim
|
|
November 29 , 2015
|
|
|
The Barry Callebaut Group, the world’s leading manufacturer of quality
chocolate and cocoa products, has signed a licensing agreement with the
Naturex Group, the leader in specialty plant-based natural ingredients.
In
April 2015, the European Commission approved the extension of Barry
Callebaut’s existing health claim on cocoa flavanols from cocoa powders
to cocoa flavanols from cocoa extracts (Regulation (EU) 2015/539). The
group obtained the right to use the health claim that “cocoa flavanols
help maintain the elasticity of blood vessels, which contributes to
normal blood flow,” for food supplements applications fitting into
delivery forms such as capsules and tablets containing high-flavanol
cocoa extracts.
For a period of five years until April 2020,
Barry Callebaut is licensing its approved 13.5 EFSA health claim on
cocoa flavanols for cocoa extract products to Naturex. As licensee,
Naturex is permitted to apply this proprietary health claim to its food
supplement solutions and its B2B clients will be also allowed to
duplicate it on their marketed end products.
Nowadays, consumer
interest in food supplements that contribute to health and well-being is
growing and tends more and more towards naturally- based products.
Additionally, heart health and obesity represent major consumer
concerns. This partnership will make it possible to offer flavanol
extracts in a convenient delivery form as food supplements, under a
consumer-friendly small daily portion that supplies the required daily
amount of 200 mg of cocoa flavanols. As part of the agreement, Barry
Callebaut and Naturex will combine their know-how and expertise that
will revolutionise the food supplement market, building strong
differentiation with existing applications in the cardiovascular health
segment:
- Barry Callebaut will supply cocoa beans naturally containing high amounts of healthy flavanols;
- From
these beans, Naturex will produce a pure cocoa extract and will market
an innovative solution with the proprietary health claim, positioned as
one of their flagship food supplement products expected to first hit the
European market in early 2016.
- Leen Allgaert, global R&D
project manager, Barry Callebaut Group, said: “With Naturex, we can now
bring the proven health benefits of cocoa flavanols which contribute to
normal blood flow in the human body to consumers in a simple 100%
natural food supplement application.”
Olivier Rigaud, CEO,
Naturex, commented: “This open innovation partnership with Barry
Callebaut is a great opportunity to bring to the food supplement market a
pure and natural breakthrough ingredient with a unique 13.5 EFSA claim
for the next five years. It will help us strengthen our global leader
position in the phytoactives segment, one of the four key categories
highlighted in our Bright2020 strategic plan, with endless applications
that will help our customers to reduce time to market, fitting perfectly
with consumer expectations.”
Eric Villain, group business unit
and marketing director, Naturex, added: “The cocoa bean is a natural
source of extraordinary phyto-actives. It offers scientifically
recognised health benefits and solutions for our self-care customers.
The sale of food supplements that contribute to health and well-being is
a field that has been experiencing strong growth in recent years. We
look forward to working with Barry Callebaut to turn this licensing
agreement into a big success for both of us.”
|
|
|
|
|
|
|
|
TOPICS
|
That foods might provide therapeutic benefits is clearly not a new concept. ...
|
|
|
|
|